THY1 and breast cancer: In breast cancer cells, Thy-1 interaction in cis is likely to play a regulatory role, maintaining integrins inactive; whereas in trans, Thy-1 triggers a signaling cascade downstream of the integrin in the cancer cell, indicating that it leads to integrin activation.